Adrian Rawcliffe's Net Worth

Adrian Rawcliffe's net worth is estimated to be at least $1,418,987.77 as of 02/07/2023. CoreStreet's estimation of Adrian Rawcliffe's net worth is based on their sale of stock and current holding of stock.

Adrian Rawcliffe is CEO at Adaptimmune Therapeutics Plc. They have executed at least 19 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,057 units of ADAP stock on 01/17/2023. Their biggest sale was on 03/20/2018 when they sold 600,000 units of Adaptimmune Therapeutics Plc stock for $1,026,000.00. They typically trade 3 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $1,418,987.77
Most recent insider trade:
  • Jan. 17, 2023

Adrian Rawcliffe's Insider Trading History

Adaptimmune Therapeutics PlcTitleAmountPriceTypeTotal Value
Jan. 17, 2023
CEO10,057$1.86Sell$18,706.02
Jan. 12, 2023
CEO18,763$1.71Sell$32,084.73
Jan. 4, 2023
CEO5,073$1.69Sell$8,573.37
Sept. 1, 2022
CEO2,536$1.97Sell$4,995.92
June 27, 2022
CEO2,562$1.63Sell$4,176.06
Jan. 18, 2022
CEO11,096$3.19Sell$35,396.24
Jan. 11, 2022
CEO14,362$3.56Sell$51,128.72
Jan. 4, 2022
CEO5,532$4.06Sell$22,459.92
Sept. 1, 2021
CEO2,782$5.20Sell$14,466.40
June 28, 2021
CEO2,794$4.37Sell$12,209.78
Jan. 19, 2021
CEO9,879$5.67Sell$56,013.93
Jan. 12, 2021
CEO2,707$6.15Sell$16,648.05
Jan. 4, 2021
CEO4,967$5.33Sell$26,474.11
Sept. 1, 2020
CEO2,776$8.51Sell$23,623.76
Aug. 3, 2020
CEO2,788$9.25Sell$25,789.00
Jan. 14, 2020
CEO3,236$5.13Sell$16,600.68
Jan. 6, 2020
CEO5,900$1.20Sell$7,080.00
Jan. 14, 2019
CFO3,084$5.37Sell$16,561.08
March 20, 2018
CFO600,000$1.71Sell$1,026,000.00